·S1 E11
From Lab to Life: Translating Ageing Science into Real-world Solutions with Professor Lorna Harries
Episode Description
Professor Lorna Harries has spent more than two decades studying why cells age and what might be done about it. In this episode, she explains one of the most overlooked mechanisms in ageing biology, RNA splicing. When cells lose control of this process, they become stressed, dysfunctional and can tip into senescence, a state that contributes to ageing across almost every organ system.
She explains what senescent cells actually do, how the signals they release can spread damage from one tissue to another, and why calling them “zombie cells” does not come close to telling the full story. We talk about the possibility of intervening before cells reach an irreversible state, why targeting the biology of ageing itself may matter more than tackling diseases one at a time, and what meaningful rejuvenation should really look like.
Prof Lorna also discusses the challenge of turning lab science into therapies through her spin-out SENISCA, her work with L’Oréal, and why conditions such as IPF are an important place to begin. Along the way, she addresses the tougher questions too, including how longevity science moves from promise to treatment, where the field risks drifting into hype, and whether these advances will be available to the many or only the few.
Links:
https://teamrna.wixsite.com/harrieslab
https://experts.exeter.ac.uk/1873-lorna-harries
Innovate UK ICURe Programme
https://iuk-business-connect.org.uk/programme/icure/
00:00 Podcast Intro Guest Setup
01:50 Meet Professor Harris Basics
02:16 DNA RNA Explained
03:38 RNA Splicing And Ageing
05:48 What Senescent Cells Do
07:38 Reversing Senescence Window
09:01 Fat Tissue And Faster Ageing
11:01 Splicing As Central Hallmark
12:11 Rejuvenation Discovery Story
13:52 From Lab To Spinout Company
16:41 Translating Science To Products
19:17 Therapy Targets IPF And Beyond
21:45 Why Translation Often Fails
23:19 Defining Real Rejuvenation
25:14 Avoiding Hype In Longevity
27:17 Who Is Lagging Behind
27:37 Regulatory Mindset Shift
28:47 Trials Built for Ageing
29:28 Scepticism and Overhype
31:25 Is Ageing a Disease
32:49 Policy and Demographic Timebomb
33:48 Advocacy and Communication
35:24 Personal Ageing Habits
36:24 Key Unasked Questions
39:15 Longevity for the Rich
41:43 Access via NHS and Patents
45:06 Rapid Fire and Myths
49:05 Closing Reflections